Cardiogenetic disease
MONDO:0100547A heterogeneous group of genetic conditions, with Mendelian (autosomal dominant, recessive, or X-linked) or chromosomal etiology that are characterized by abnormalities in the cardiovascular system.
Also known as: hereditary heart disease
614 clinical trials for this condition and its sub-types, 3 tagged with Cardiogenetic disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Cardiogenetic disease
-
Familial cardiomyopathy 2 trials · 217 incl. sub-types
9 sub-types
- Familial hypertrophic cardiomyopathy 2 trials · 85 incl. sub-types Sub-types →
- Familial restrictive cardiomyopathy 0 trials · 62 incl. sub-types Sub-types →
- Familial dilated cardiomyopathy 7 trials · 60 incl. sub-types Sub-types →
- Familial isolated arrhythmogenic right ventricular dysplasia 0 trials · 10 incl. sub-types Sub-types →
- PRKAG2-related cardiomyopathy 2 trials · 4 incl. sub-types Sub-types →
- Left ventricular noncompaction 3 trials · 4 incl. sub-types Sub-types →
- NKX2.5-related congenital, conduction and myopathic heart disease 0 trials
- Naxos disease 0 trials
- Fatal infantile encephalocardiomyopathy 0 trials Sub-types →
-
Atrial septal defect 45 trials · 78 incl. sub-types
15 sub-types
- Patent foramen ovale 36 trials
- Atrial septal defect, ostium secundum type 8 trials
- Atrial septal defect 2 1 trial
- Lutembacher syndrome 0 trials
- Atrial septal defect 1 0 trials
- Atrial septal defect 3 0 trials
- Atrial septal defect 4 0 trials
- Atrial septal defect 5 0 trials
- Atrial septal defect 6 0 trials
- Atrial septal defect 7 0 trials
- Atrial septal defect 8 0 trials
- Atrial septal defect 9 0 trials
- Atrial septal defect, coronary sinus type 0 trials
- Atrial septal defect, ostium primum type 0 trials
- Atrial septal defect, sinus venosus type 0 trials
-
Cardiogenetic rhythm disorder 2 trials · 67 incl. sub-types
9 sub-types
- SCN5A-related cardiac rhythm disorder 0 trials · 47 incl. sub-types Sub-types →
- Paroxysmal familial ventricular fibrillation 2 trials · 27 incl. sub-types Sub-types →
- Progressive familial heart block 0 trials · 19 incl. sub-types Sub-types →
- Ventricular tachycardia, familial 1 trial · 11 incl. sub-types Sub-types →
- Brugada syndrome 10 trials Sub-types →
- Familial atrial fibrillation 0 trials · 1 incl. sub-types Sub-types →
- Short QT syndrome 1 trial Sub-types →
- Atrial conduction disease 0 trials
- Familial sick sinus syndrome 0 trials Sub-types →
-
Tetralogy of fallot 33 trials
-
Patent ductus arteriosus 28 trials
4 sub-types
- Char syndrome 0 trials
- PDA1 0 trials
- Patent ductus arteriosus 2 0 trials
- Patent ductus arteriosus 3 0 trials
-
Ventricular septal defect 24 trials · 26 incl. sub-types
5 sub-types
- Double outlet right ventricle 2 trials · 3 incl. sub-types Sub-types →
- Anterior deviation infundibular septum 0 trials
- Ventricular septal defect 1 0 trials
- Ventricular septal defect 2 0 trials
- Ventricular septal defect 3 0 trials
-
Familial bicuspid aortic valve 6 trials · 21 incl. sub-types
3 sub-types
- Aortic valve disease 1 16 trials
- Aortic valve disease 2 12 trials
- Aortic valve disease 3 0 trials
-
NOTCH1-related AOS spectrum disorder 0 trials · 16 incl. sub-types
2 sub-types
- Aortic valve disease 1 16 trials
- Adams-Oliver syndrome 5 0 trials
-
Alagille syndrome 15 trials
3 sub-types
-
DiGeorge syndrome 11 trials
-
Hypoplastic left heart syndrome 9 trials
2 sub-types
- Hypoplastic left heart syndrome 1 0 trials
- Hypoplastic left heart syndrome 2 0 trials
-
CHARGE syndrome 4 trials
1 sub-type
- CHD7-related CHARGE syndrome 0 trials
-
Velocardiofacial syndrome 4 trials
-
Supravalvular aortic stenosis 3 trials
-
4 sub-types
- Congenital heart defects, multiple types, 6 0 trials
- Congenitally uncorrected transposition of the great arteries with cardiac malformation 0 trials
- Congenitally uncorrected transposition of the great arteries with coarctation 0 trials
- Isolated congenitally uncorrected transposition of the great arteries 0 trials
-
Ellis-van Creveld syndrome 1 trial
1 sub-type
- Jeune syndrome situs inversus 0 trials
-
Dextrocardia 1 trial
-
Inherited mitral valve disease 0 trials · 1 incl. sub-types
2 sub-types
- Familial mitral valve prolapse 0 trials · 1 incl. sub-types Sub-types →
- Congenital mitral stenosis 0 trials
-
Structural congenital heart disease, multiple types - GATA4 0 trials · 1 incl. sub-types
3 sub-types
- Atrial septal defect 2 1 trial
- Atrioventricular septal defect 4 0 trials
- Ventricular septal defect 1 0 trials
-
8q24.3 microdeletion syndrome 0 trials
-
3 sub-types
-
CHIME syndrome 0 trials
-
2 sub-types
-
GATA6-related congenital heart disease with or without pancreatic agenesis or neonatal diabetes 0 trials
2 sub-types
- Atrial septal defect 9 0 trials
- Atrioventricular septal defect 5 0 trials
-
Holt-Oram syndrome 0 trials
1 sub-type
- Heart-hand syndrome type 3 0 trials
-
Larsen-like syndrome, B3GAT3 type 0 trials
-
Peters plus syndrome 0 trials
-
Sengers syndrome 0 trials
-
TARP syndrome 0 trials
-
2 sub-types
- Char syndrome 0 trials
- Patent ductus arteriosus 2 0 trials
-
TNNT2-related cardiomyopathy 0 trials
3 sub-types
- Cardiomyopathy, familial restrictive, 3 0 trials
- Dilated cardiomyopathy 1D 0 trials
- Hypertrophic cardiomyopathy 2 0 trials
-
Cardiac valvular dysplasia, X-linked 0 trials
-
3 sub-types
-
Familial atrial myxoma 0 trials
-
6 sub-types
- Atrioventricular septal defect 0 trials
- Atrioventricular septal defect 4 0 trials
- Atrioventricular septal defect 5 0 trials
- Complete atrioventricular canal 0 trials Sub-types →
- Congenital heart defects, multiple types, 4 0 trials
- Partial atrioventricular canal 0 trials
-
Mehta lewis patton syndrome 0 trials
-
Pericardial effusion, chronic 0 trials
-
Transketolase deficiency 0 trials
-
Tricuspid atresia 0 trials
Most studied deeper sub-types
-
New cancer pill shows early promise, but trial halted
Disease control Stopped earlyThis early-stage trial tested an oral drug called TNO155, alone or with another drug (nazartinib), in 227 adults with advanced solid tumors like lung cancer, melanoma, and head/neck cancer. The main goal was to check safety and find the right dose. The study was terminated early,…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Heart drug study halted early: what we know
Disease control Stopped earlyThis study tested an experimental drug called CRD-4730 in people with a rare inherited heart rhythm disorder (CPVT) that can cause dangerous fast heartbeats. Seven adults received two different doses of the drug and a placebo to check safety and how the body processes it. The stu…
Phase 2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Abandoned study: can a common painkiller help close a tiny heart vessel in preemies?
Disease control Stopped earlyThis study tested whether adding acetaminophen to standard ibuprofen treatment could better close a blood vessel (ductus arteriosus) that stays open too long in very premature infants. The trial was planned for preterm babies born at or before 27 weeks and 6 days who needed breat…
Phase 2 • Sponsor: University of South Alabama • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Hope dashed: drug trial for Post-COVID racing heart stopped early
Disease control Stopped earlyThis study tested a drug called IgPro20 (HIZENTRA) to see if it could help people with post-COVID POTS, a condition that causes a rapid heart rate and dizziness when standing. The trial was stopped early after enrolling only 16 adults. The goal was to see if the drug could reduce…
Phase 3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental gene therapy for rare muscle disease shows early promise but study halted
Disease control Stopped earlyThis study tested a gene therapy called SRP-9003 for people with limb-girdle muscular dystrophy type 2E (LGMD2E), a rare genetic disease that causes muscle weakness. The treatment aimed to deliver a working gene to muscle cells to help them produce a missing protein. Only 6 peopl…
Phase 1/2 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Experimental drug for Post-COVID POTS study halted early
Disease control Stopped earlyThis study looked at the long-term safety of efgartigimod in adults with post-COVID postural orthostatic tachycardia syndrome (POTS), a condition causing rapid heart rate and dizziness upon standing. The trial was an open-label extension for people who completed a previous study.…
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Pompe disease drug trial halted after just 3 patients
Disease control Stopped earlyThis study tested an oral drug called duvoglustat in adults with Pompe disease, a rare genetic disorder that causes muscle weakness. Only 3 people took part, and the study was stopped early. Researchers looked at safety and whether the drug could improve walking distance and othe…
Phase 2 • Sponsor: Amicus Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 16:43 UTC
-
Experimental gene therapy tested for rare muscular dystrophy
Disease control Stopped earlyThis early-stage trial tested a gene therapy called SRP-9004 in just 4 people with limb girdle muscular dystrophy type 2D/R3, a rare muscle-weakening disease. The main goal was to check safety, not effectiveness. The study was terminated early, so results are limited.
Phase 1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:47 UTC
-
Heart hole closure for migraines? tiny study halted early
Symptom relief Stopped earlyThis study tested whether closing a small hole in the heart (called a PFO) with a device could reduce migraine headaches. It planned to compare the real procedure to a sham (fake) procedure in adults aged 18-55 with frequent migraines. However, the study was stopped early after e…
Sponsor: W.L.Gore & Associates • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Mindfulness may ease anxiety for heart device patients
Symptom relief Stopped earlyThis study tested whether a mindfulness program (including meditation, body scans, and gentle yoga) could help people with implanted heart devices like ICDs or pacemakers feel less anxious, stressed, and depressed. The study planned to enroll 34 adults who had recently received s…
Sponsor: Chien Chih-Yin • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Scientists dive into cells to unravel costello Syndrome's secrets
Knowledge-focused Stopped earlyThis study collects small skin samples from children aged 2 to 17 with Costello syndrome or a related condition. Researchers will analyze the cells to understand how a mutation in the HRAS gene affects energy use and mitochondria. The goal is to learn more about the disease's und…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Hidden heart condition: study seeks to uncover missed diagnosis in heart failure patients
Knowledge-focused Stopped earlyThis study aims to find out how common transthyretin amyloidosis cardiomyopathy (ATTR-CM) is in Russian patients with a certain type of heart failure. Researchers will review medical records and then invite some patients for extra heart tests to confirm or rule out ATTR-CM. The g…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:47 UTC